Cyclerion Therapeutics 대차 대조표 상태
재무 상태 기준 확인 4/6
Cyclerion Therapeutics has a total shareholder equity of $8.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $10.1M and $1.3M respectively.
주요 정보
0%
부채 비율
US$0
부채
| 이자 보상 비율 | n/a |
| 현금 | US$4.59m |
| 주식 | US$8.78m |
| 총 부채 | US$1.28m |
| 총 자산 | US$10.07m |
최근 재무 상태 업데이트
We're Keeping An Eye On Cyclerion Therapeutics' (NASDAQ:CYCN) Cash Burn Rate
Aug 09
We're Keeping An Eye On Cyclerion Therapeutics' (NASDAQ:CYCN) Cash Burn Rate
Mar 03Recent updates
Cyclerion stock tanks 32% on workforce reduction, clinical development refocus
Oct 06We're Keeping An Eye On Cyclerion Therapeutics' (NASDAQ:CYCN) Cash Burn Rate
Aug 09We're Keeping An Eye On Cyclerion Therapeutics' (NASDAQ:CYCN) Cash Burn Rate
Mar 03Cyclerion Therapeutics: Distressed Spinoff Developing New Medicines For CNS Disorders
Oct 26Cyclerion Therapeutics: Insiders Buying With No Clinical Data Due Until YE 2021
Jun 21Cyclerion climbs on a series of insider purchases
Jun 08Cyclerion updates on clinical trial progress at webinar
Apr 28Who Has Been Buying Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) Shares?
Mar 09What Kind Of Shareholders Hold The Majority In Cyclerion Therapeutics, Inc.'s (NASDAQ:CYCN) Shares?
Jan 28
Cyclerion Therapeutics +10.5% after prelim reports
Jan 13Cyclerion Therapeutics announces promotions
Dec 21Can You Imagine How Cyclerion Therapeutics' (NASDAQ:CYCN) Shareholders Feel About The 40% Share Price Increase?
Dec 20Cyclerion Therapeutics reports Q3 results
Nov 05재무 상태 분석
단기부채: CYCN's short term assets ($4.7M) exceed its short term liabilities ($1.3M).
장기 부채: CYCN has no long term liabilities.
부채 대 자본 내역 및 분석
부채 수준: CYCN is debt free.
부채 감소: CYCN had no debt 5 years ago.
대차 대조표
현금 런웨이 분석
과거에 평균적으로 적자를 기록했던 기업의 경우, 최소 1년 이상의 현금 유동성을 보유하고 있는지 평가합니다.
안정적인 현금 활주로: CYCN has less than a year of cash runway based on its current free cash flow.
예측 현금 활주로: CYCN has less than a year of cash runway if free cash flow continues to grow at historical rates of 28.7% each year.